Chemokines as mediators of allergic inflammation

International Archives of Allergy and Immunology

Volumn 109, Issue 2, 1996, Pages 97-109

  Bacon, Kevin B ^a   Schall, Thomas J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adhesion; Chemokines; Inflammation; Leukocytes

Indexed keywords

CELL ADHESION MOLECULE; CELL RECEPTOR; CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; PROTEIN;

ALLERGY; BLOOD; CELL ADHESION; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; LYMPH VESSEL; LYMPHOID ORGAN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030045809     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237207     Document Type: Article

References (109)

1. Schall TJ: Biology of the RAMI: SIS cytokine gene family, Cytokine 1991:3:165-183.
2. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proin-flammatory supergene ‘intercrine’ cytokine family, Annu Rev Immunol 1991:9:617-648.
3. Baggiolini M, Devvald B, Moser B: lnterleu-kin-8 and related chemotactic cytokines - C'XC and CC chemokines, Adv Immunol 1994:55: 97-179.
4. Schall TJ: The chemokines; in Thompson A (ed): The Cytokine Handbook, ed, 2. New York, Academic Press, 1994: pp 419-160.
5. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking and inflammation, Curr Opin Immunol 1994:6:865-873.
6. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation, Immunol Today 1994: 104:27-29.
7. Keiner GS, Kennedy J, Bacon KB, Kleycn-steuber S, Largaespada DA, Jenkins NA, Copeland NO, Bazan JP, Moore KW, Schall TJ, Zlot-nik A: Lymphotactin: A novel cytokine which represents a new class of chemokine, Science 1994:266:1395-1399.
8. Schall TJ, Bacon K, Toy K, Goeddel DV: Selective attraction of moncytcs and T lymphocytes of the memory phenotype by cytokine RANTES, Nature 1990:347:669-67
9. L Kameyoshi Y, Dorschncr A, Mallet AI, Christophers P, Schroder JM: Cytokine R ANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils, J Exp Med 1992:176:587-592.
10. Miyamasu MI, Lirai K, Takahashi Y, Itda M, Ya-maguchi M, Koshino T, Takaishi T, Morita Y, Ohta K, Kasahara T, Ito K: Chemotactic agonists induce cytokine generation in eosinophils, J Immunol 1995:154:1339-1349.
11. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Tony NF, Truong O, Ilsuan JJ, Williams TJ: Eotaxin: A potent eosinophil chemo attractant cytokine detected in a guinea pig model of allergic airways inflammation, JExp Med 1994:179:881-887.
12. Rothenberg ME, Luster AD, Lilly CM, Drazcn JM, Leder P: Constitutive and allergen-induced expression of eotaxin in the guinea-pig lung, J Exp Med 1995:181:1211-1216.
13. Standiford TJ, Kunkel SL, Basha MA, Chcnsuc SW, Lynch JP, Tocws GB, Westwick J, Stricter RM: Interleukin 8 gene expression by pulmonary epithelial cell line: A model for cytokine networks in the lung, J Clin Invest 1990:86: 1945.
14. Rolfe MW, Kunkel SL, Standiford TJ, Chcnsuc SW, Allen RM, Evanoff HL, Phan SH, Stricter RM: Pulmonary fibroblast expression of interleukin-8: A model for alveolar macrophage-derived cytokine networking, Am J Respir Cell Mol Biol 1991;5:493-501.
15. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Stricter RM: Alveolar-macrophage-derivcd cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type ll-likc epithelial cells, J Biol Chcm 1991:266: 9912.
16. Van Damme J, Proost P, Put W, Arens S, Le-nacrts JP, Conings R, Opdenakker G, Heremans II, Billiau A: Induction of monocyte chemotactic proteins MCP-I and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers, J Immunol 1994;152:5495-5502.
17. Becker S, Quay I, Korcn IIS, Haskill IS: Constitutive and stimulated MCP-I, GROa, ß and y expression in human airway epithelium and bronchoalveolar macrophages, Am J Physiol 1994;266:278-286.
18. Murwitz AA, Lyman WD, Berman JW: Tu-mour-necrosis factor-u and transforming growth factor ß up-rcgulate astrocyte expression of monocyte chemoattractant protein-1. J Ncuroimmunol 1995:57:193-198.
19. Brown Z, Gerristcn ME, Carley WW, Strietcr RM, Kunkel SL, Westwick J: Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells Differential regulation of monocyte chemoattractant protein-1 and intcrleukin-8 in response to inter-feron-y, Am J Pathol 1994:145:913-921.
20. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity, Cell 1991:67:1033-1036.
21. Picker LJ, Butcher EC: Physiological and molecular mechansims of lymphocyte homing, Annu Rev Immunol 1992;10:561-591.
22. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell 1994:76:301-314.
23. Issekutz TB, Stoltz JM, Webster DM: Role of interferon in lymphocyte recruitment into the skin, Cell Immunol 1986:99:322-333.
24. Issekut TB, Stoltz JM: Stimulation of lymphocyte migration by endotoxin, tumour necrosis factor, and interferon, Cell Immunol 1989:120: 165- 173.
25. Colditz IG: Desensitization mechanisms regulating the plasma leakage and neutrophil emigration: in Gordon JL (ed): Vascular Endothelium: Interactions with Circulating Cells: New York, Elsevier, 1991. pp 175-187.
26. Smith CW, Kishimoto TK, Abbass O, Hughes B, Rothlcin R, Mclntirc LV, Butcher E, Anderson DC: Chemotactic factors regulate lectin adhesion molecule I (I, EC AM -1)-dependent neutrophil adhesion to cytokine-stimulated endothelial eells in vitro J Clin Invest 1991:87:609-618.
27. Boclmer BA, Luscinskas FW, Gimbrone MA Jr., Newman W, Sterbinski SA, Dersc-Anthony CP, Klunk D, Schleimer RP: Adhesion of human basophils, eosinophils and neutrophils to interleukin-1-activated human vascular endothelial cells: Contribution of endothelial cell adhesion molecules, J Exp Med 1991; 173:1553-1556.
28. Schleimer RP, Sterbinski SA, Kaiser J, Bickcl CA, Klunk DA, Tonoika K, Newman W, Luscinskas FW, Gimbrone MA Jr., McIntyre BW, Bochner BS: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VC AM-1. J Immunol 1992:148:1086-1092.
29. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix, Adv Immunol 1993:54:271-335.
30. Iazaar AL, Pure E: CD44: A model for regulated adhesion function, Immunologist 1995:3: 19-25.
31. lssekutz TB: Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody: A likely role for VLA-4 in vivo, I Immunol 1991;147:4178-4184.
32. lssekutz TB: Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delaycd-type hvpersensitivity-induced inflammation, Am, I Pathol 1994; 143:1286- 1293.
33. Yoshimura T, Robinson LA, Tanaka S, Appella E, Leonard EJ: Purification and amino acid analysis of two human monocyte ehemoattrac-tants produced by phytohcmagglutinin-stimu-lated blood mononuclear leukocytes, J Immunol 1989; 142:1956-1962.
34. Rollins BJ, Walz A, Baggiolini M: Recombinant human MCP-I/JE induces chemotaxis, calcium llux and the respiratory burst in human monocytes, Blood 1991:78:1112-1116.
35. Wolpe SD, Cerami A: Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines, FASLB J 1989:3:2565-2573.
36. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotaetie for T lymphocytes, Science 1989:243:1464-1466.
37. Bacon KB, Westwiek I, Camp RDR: Potent and specific inhibition of IL-8. IL-lu- and IL-I-induced lymphocyte migration by calcium channel antagonists, Biochem Biophys Res Commun 1989;165:349-354.
38. Bacon KB, Fincham NJ, Quinn DO, Camp RDR: Tissue-derived leukocyte attractant factors in inflammation: in ArmitageJP, Lackie JM (eds): Biology of the Chemotaetie Response, Soe Gen Microbiol 46. Cambridge, Cambridge University Press, 1990. pp 379-393.
39. Xu L, Kelvin DI, Ye GQ, Taub DD, Bcn-Baruch A, Oppenheim JJ, Wang JM: Modulation of IL-8 receptor expression on purified human T lymphocytes is associated with changed che-motactic responses to IL-8. J Leukoc Biol 1995: 57:335-342.
40. Bacon KB, Florcs-Romo L, Life PF, Taub DD, Premaek BA, Arkinstall SJ, Wells TNC, Schall TJ, Power CA: IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D, J Immunol 1995:154:3654-3666.
41. Schall TJ, Bacon K, Camp RDR, Kaspari JW, Goeddel DV: Human macrophage inflammatory protein a (MIP-lu) and MIP-1ß attract distinct populations of lymphocytes, J Exp Med 1993:177:1821-1825.
42. Loetscher P, Seitz VI, Clark-Lewis I, Baggiolini M, Moser B: Monocyte chemotaetie proteins MCP-I, MCP-2 and MCP-3 are major attrac-tants for human CD4+ and CD8+ T lymphocytes, FASEB J 1994:8:1055-1060.
43. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chcmoattractant protein I acts as a T-lymphocytc chcmoattractant, Proc Natl Acad Sei USA 1994:91:3652-3656.
44. Scbok K, Woodside D, Al-Aoukaty A, Ilo AD, Bluck S, Maghazachi AA: IL-8 induces the locomotion of lL-2-aclivatcd natural killer cells, J Immunol 1993:150:1524-1534.
45. Maghazachi AA, Al-Aoukaty A, Schall TJ: C-C chemokines induce the chemotaxis of natural killer and IL-2-activated natural killer cells: A role for G-proteins, J Immunol 1994: 153:4969-4977.
46. Allavena P, Bianchi G, Zhou D, van Damme J, Jilek P, Sozzani S, Mantovani A: Induction of natural killer cell migration by monocyte chc-motaetic protein-1. protein-2 and protein-3. Fur J Immunol 1994:24:3233-3236.
47. Rot A, Krieger VI, Brunner T, Bischoff SG, Schall I J, Dahinden CA: RANTF, S and macrophage inflammatory protein-lu induce the migration and activation of human eosinophil granulocytes, J Exp Med 1992:176:1489-1495
48. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown VI, Grant J, RANTF, S is a chemotaetie and activating factor for human eosinophils, J Immunol 1993:150:3442-3448.
49. Dahinden CA, Geiser T, Brunner T, von Tschar-ner V, Caput I, Ferrara P, Minty A, Baggiolini M: Monoevtc chemotaetie protein 3 is a most effective basophil and eosinophil-activating ehemokine, J Exp Med 1994:179:751-756.
50. Bruijnzccl PLB, Kuijper PH VI, Rihs S, Betz S, Warringa RAJ, Kconderman L: Eosinophil migration in atopic dermatitis, 1: Increased migrators responses to N-formyl-mcthionyl-lcueyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J Invest Dermatol 1993:100:137-142.
51. Schweizer RC, Weimers BAC, Raaijmakers JA VI, Zanen P, Latnmers JWJ, Koenderman L: RANTES- and interleukin-8-induced responses in normal human eosinophils: Effects of priming with interleukin 5. Blood 1994:83:3697-3704.
52. Dahinden CA, Kurimoto Y, De Weck AL, Lind-Icy I, Dewald B, Baggiolini VI: The neutrophil activating peptide NAF NAP-1 induces histamine and leukotrienc release by interleukin 3 primed basophils J Exp Med 1989:170:1787.
53. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP: Monocyte chemotaetie and activating factor is a potent histamine releasing factor for human basophils, J Exp Med 1992:175: 489-493.
54. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Vicksman MY, Kaplan AP: RANTES, a monocyte and T lymphocyte chemotaetie cytokine releases histamine from human basophils, J Immunol 1992:149:636-642.
55. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA: Macrophage inflammatory protein I activates basophils and mast cells, J Exp Med 1992:176:781.
56. Alam R, Forsythe P, Stafford SI, leinrich J, Bravo R, Proost P, Van Damme J: Monocyte che-motactic protein-2. monocyte chemotaetie protein-3 and fibroblast-induced cytokine, MCP-2. 3 and FIC: Three new chemokines induce Chemotaxis and activation of basophils, J Immunol 1994:153:3155-3159.
57. Taub D, Dastvch J, Inamura N, Upton J, Kelvin D, Metcalfe D, Oppenheim J: Bone marrow-derived mast cells migrate, but do not degranulate, in response to chemokines, J Immunol 1995: 154:2393-2402.
58. Gintbrone MA Jr., Obin MS, Brock AF, Euis EA, Hass PE, Hebert CA, Yip YK, Leung DW, Lowe DG, Kohr WJ, Darhonnc WC, Bechtol KB, Baker JB: Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions, Science 1989:246:1601-1603.
59. Luscinskas IW, Kicly JM, Ding II, Obin MS, Hebert CA, Baker JB, Gimbrone MA Jr.: In vitro inhibitory effect of IL-8 and other chemoattrac-tants on neutrophil-endothelial adhesive interactions, J Immunol 1992:149:2163-2171.
60. Smith WB, Gamble JR, Clark-Lcwis I, Vadas VIA; lnterleukin-8 induces neutrophil transen-dothelial migration, Immunology 1991:72:65-72.
61. Huber AR, Kunkel SL, Todd Rl III, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous ititerleukin-8. Science 1991:254:99-102.
62. Tanaka Y, Adams DIL, Hubseher S, Hirano II, Sicnbilist U, Shaw S: T cell adhesion induced by proteoglycan-immobilized cytokine MIP-lß, Nature 1993:361:79-82.
63. Taub DD, Lloyd AR, Conlon K, Wang JM, Or-taldo JR, Harada A, Matsushima K, Kelvon DJ, Oppenheim JJ: Recombinant human interferon-inducible protein 10 is a chemoaltractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells, J Exp Med 1993:177:1809-1814.
64. Brezinschek RL, Lipsky PE, Galea P, Vita R, Oppenheimcr-Marks N: Phenotypic charctcri-zation of CD4+ T cells that exhibit a transendothelial migratory capacity, J Immunol 1995; 154:3062-3077.
65. Gilat D, Hershkoviz R, Mekori YA, Vlodavsky I, Lider O: Regulation of adhesion of CD4+ T lymphocytes to intact or hcparinase-trcatcd subendothelial extracellular matrix by diffusa-ble or anchored RANTES and VHP-1β. J Immunol 1994;153:4899-4906.
66. Lukács NW, Stricter RVI, Einer VM, Evanoff HL, Burdick VI, Kunkel SL: Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-I« during monocyte-endothelial cell interactions, Blood 1994:83: 1174-1178.
67. Jiang Y, Zhu IE, Luscinskas FW, Graves DT: MCP-I-stimulated monocyte attachment to la-minin is mediated by (32 integrins, Am J Physiol 1994:267:1112-1118.
68. Vaddi K, Newton RC: Regulation of monocyte integrin expression by 3-family chemokines, J Immunol 1994:153:4721-4732.
69. Shaw J, Messier JM, Mercurio AM: The activation dependent adhesion of macrophages to laminin involves cyloskcletal anchoring and phosphorylation of the «634 integrin, J Cell Biol 1990:110:2167-2174.
70. Lee EC, Lotz MVI, Steele JD Jr., Mercurio AM: The integrin «634 is a laminin receptor, J Cell Biol 1992;117:671-678.
71. Georas SN, McIntyre BW, Ebisawa M, Bed-narckyk JI, Sterbinsky SA, Schleimer RP, Bochner BS: Expression ofa functional lamintn receptor a6ß I, very late activation antigen 6 on human eosinophils, Blood 1993:82:2872-287.
72. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP: Eosinophil Iransendolhelia! migration induced by cytokines, Ill: Effect of the chcmokine RANTES, J Immunol 1994:153: 2153 - 2159.
73. Bacon KB, Flores-Romo L, Aubry JP, Wells INC, Power CA: Interleukin 8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers, Immunology 1994;82:473-481
74. Forrest MJ, Eiennann GJ, Meurcr R, Walako-vits LA, MacIntyre DE: The role of CD 18 in IL-8 induced dermal and synovial inflammation, Br J Pharmacol 1992:106:287-294.
75. Nourshargh S, Perkins JA, Showcll HJ, Matsushima K, Williams TJ, Collins PD: A comparative study of the neutrophil stimulatory activity in vitro and proinflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol 1992; 148:106-111.
76. Kudo C, Araki A, Matsushima K, Scndo F: Inhibition of IL-8-induced W3/25+ (CD4+) T lymphocyte recruitment into subcutaneous tissue of rats by selective depletion of in vivo neutrophils w ith a monoclonal antibody, J Immunol 1991:147:2196-2201.
77. Heinrich JN, Bravo R: The orphan mouse receptor interleukin ILI-8RB binds N5I, J Biol Client 1995:270:4987-4989.
78. Collins PD, Weg VB, Faccioli LI I, Watson ML, Moqbel R, Williams TJ: Eosinophil accumulation induced by human interlcukin-8 in the guinea-pigin vivo, Immunology 1993:79:312-318.
79. Perretti M, Harris JG, Flower RJ: A role for endogenous histamine in interleukin-8-indueed neutrophil infiltration into mouse air-pouch Investigation of the modulatory action of systemic and local dexamethasone, Br J Pharmacol 1994:112:801-808.
80. Simone WS, Ilughcs IM, Nguyen IIQ, Trebas-ky ID, Danilcnko DM, Mcdlock ES: Longterm impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994:94:1310-1319.
81. San MJ, Weg VB, Bolanowski MA, Nourshargh S: IL-1 is a potent inducer of eosinophil accumulation in rat skin, J Immunol 1995:154: 1364-1373.
82. Meurcr R, Riper GV, Feeney W, Cunningham P Jr., Springer MS, MacIntyre DE, Rosen H: Formation of eosinophilic and monocytic intrader-mal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattraetant protein I, human macrophage inflammatory protein lu or interleukin 8. J Exp Med 1993:178:1913-1921.
83. Di Sabato G (ed): Immunochemical techniques Part L: Chemotaxis and inflammation, Methods Enzymol 1988:162.
84. Rot A: Neutrophil attractant/activation pro-tein-l: (lnterleukin-8) induced in vitro neutrophil migration by haptotactic mechanism, Eur J Immunol 1993:23:303-306.
85. Webb EMC, Lhrengruber MU, Clark-Lewis I, Baggiolini M, Rot A: Binding to heparan sulphate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sei USA 1993: 90:7158-7162.
86. Witt DP, Lander AD: Differential binding of chcmokines to glyeosaminoglycan subpopulations, Curr Biol 1994:4:394-400.
87. Fincham NJ, Camp RDR, Gearing AJH, Bird CR, Cunningham I'M: Neutrophil chemoattrac-tant and IL-1-like activity in samples from psoriatic skin: Further characterization, J Immunol 1988:140:4294-4299.
88. Schroder JM, Christophers E: Identification of C5aj and an anionic neutrophil activating peptide (ANAP) in psoriatic scales, J Invest Dermatol 1986:87:53-58.
89. Mulligan MS, Jones ML, Bolanowski MA, Ba-ganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA: Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody, J Immunol 1993:150:5585-5595.
90. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA: Role of macrophage inflammatory protein-la (MIP-Ia) in acute lung injury in rats, J Immunol 1995;154:4793-4802.
91. Sckido N, Mukaida N, Harada A, Nakanishi I, Watanabc Y, Matsushima K: Prevention of lung repcrfiision injury in rabbits by a monoclonal antibody against interleukin 8. Nature 1993: 365:654-657.
92. McElvaney NG, Nakamura H, Birrer P, Hebert CA, Wong WL, Alphonso M, Baker IB, Catalano MA, Crystal RG: Modulation of airway inflammation in cystic fibrosis, J Clin Invest 1992;90:1296-1301.
93. Donnelly SC, Stricter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Ilaslett C: lnterleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups, Lancet 1993:341:643-647.
94. Hack CE, Hart M, Strack van Schijndc RIM, Eerenberg AIM, Nuijens JH, Thijs LG, Aarden LA: lnterleukin-8 in sepsis: Relation to shock and inflammatory mediators, Infect Immun 1992:60:2835-2842.
95. Broaddus VC, Hebert CA, Vitangcol RV, Hoef-fcl JM, Bernstein MS, Boylan AM: lnterlcu-kin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema, Am RevRcspirDis 1992:146:825-830.
96. Becker S, Quay J, Soukup J: Cytokine (tumor necrosis factor, IL-6. IL-8) production by respiratory syncytial virus-infeclcd human alveolar macrophages, J Immunol 1991:147:4307 4312.
97. Nakamura II, Yoshimura K, McElvaney NG, Crystal RG: Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interlcukin-8 gene expression in a human bronchial epithelial cell line, J Clin Invest 1992:89:1478- 1484.
98. Antoniadcs UN, Neville-Golden J, Galano-poulos T, Kradin RL, Valente AJ, Graves DT: Expression of monocyte chemoattraetant protein I mRNA in human idiopathic pulmonary fibrosis, Proc Natl Acad Sei USA 1992:89: 5371 5375.
99. Griffiths CEM, Barker JNWN, Kunkel SL, NickololTBJ: Modulation of leukocyte adhesion molecules, a T-ccll chcmotaxin (IL-8) and a regulatory cytokine (TNF-a) in allergic contact dermatitis(rhusdermatitis), BrJ Dermatol 1991:124:519-526.
100. Standiford TJ, Rolfe MW, Kunkel SL, Lynch JP, Burdick MD, Gilbert AR, Orringer MB, Whyte RL Stricter RM: Macrophage inflammatory protein-la expression in interstitial lung disease, J Immunol 1993:151:2852.
101. Beck LA, Schall TJ, Beall LD, Leopold D, Bickel C, Baroody F, Naclcrio RM, Schleimer RP: Detection of the chcmokine RANTES and activation of vascular endothelium in nasal polyps, J Allergy Clin Immunol 1994:93:234.
102. Alam R, York J, Boyars M, Grant JA, Stafford S, Forsythe P, Lee J, Weido A: Detection and quantitation of RANTES and M IP-1 it in bron-choalvcolar lavage (BAL) fluid and their mRNA in lavage cells, J Allergy Clin Immunol 1994:93:183.
103. Rosenthal GJ, Germolec DR, Blazka ME, Cor-sini E, Simeonova P, Pollock P, Kong LY, Kvvon J, Luster Ml: Asbestos stimulates IL-8 production from human lung epithelial cells, J Immunol 1994:153:3237-3244.
104. Smith RE, Stricter RM, Phan SII, Lukács NW, Huffnagle GB, Wilke CA, Burdick MD, Lincoln P, EvanoffH, Kunkcl SL: Production and function of murine macrophage inflammatory protein-1 a in blcomvcin-induced lung injury, J Immunol 1994:153:4704-4712.
105. Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SI I: Lung monocyte chemo-attractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis, J Immunol 1994:153:4733-4741.
106. VanOtteren GM, Stricter RM, Kunkel SL, Paine R, Greenberger MJ, Danforth JM, Burdick MD, Standiford TJ: Compartmentalized expression of RANTES in a murine model of endotoxemia, J Immunol 1995:154:1900-1908.
107. Lukács NW, Stricter RM, Shaklcc CL, Chen-sue SW, Kunkel SL: Macrophage inflammatory protein-let influences eosinophil recruitment in antigen-specific airway inflammation, Eur J Immunol 1995:25:245-251.
108. Devcrgne O, Marfaing-Koka A, Schall TJ, Leger-Ravet MB, Sadick M, Peuchmaur M, Crevon MC, Kim T, Galanaud P, Emilie I: Production of the RANTES chcmokine in de-layed-typc hypersensitivity reactions: Involvement of macrophages and endothelial cells, J Exp Med 1994:179:1689-1694.
109. Marfaing-Koka A, Devcrgne Q, Gorgonc G, Portier A, Schall TJ, Galanaud P, Emilie I: Regulation of the production of the RANTES chcmokine by endothelial cells: Synergistic induction by IFN-y plus TNF-a and inhibition by II,-4 and 1L-13.J Immunol 1995:154:1870- 1878.